Evidence map›Paper›PMID 39820364›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2025

Communicating cancer treatment with pictogram-based timeline visualizations.

Helena Klara Jambor, Julian Ketges, Anna Lea Otto, Malte von Bonin, Karolin Trautmann-Grill, Raphael Teipel, Jan Moritz Middeke, Maria Uhlig, Martin Eichler, Sebastian Pannasch and 1 more

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Informational needs in vulvar cancer and precursor conditions: a social listening study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. The graphical abstract.Nature methods · 2026
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Helena Klara JamborNational Center for Tumor Diseases, University Cancer Center, NCT-UCC, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0003-3397-1842
Julian KetgesNational Center for Tumor Diseases, University Cancer Center, NCT-UCC, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.
Anna Lea OttoEngineering Psychology and Applied Cognitive Research, Faculty of Psychology, Technische Universität Dresden, 01069 Dresden, Germany.
Malte von BoninMedical Clinic 1, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0002-2995-3230
Karolin Trautmann-GrillMedical Clinic 1, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0002-9050-1049
Raphael TeipelMedical Clinic 1, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.
Jan Moritz MiddekeMedical Clinic 1, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.
Maria UhligMedical Clinic 1, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.
Martin EichlerNational Center for Tumor Diseases, University Cancer Center, NCT-UCC, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0001-9654-2207
Sebastian PannaschEngineering Psychology and Applied Cognitive Research, Faculty of Psychology, Technische Universität Dresden, 01069 Dresden, Germany.ORCID 0000-0002-6673-9591
Martin BornhäuserNational Center for Tumor Diseases, University Cancer Center, NCT-UCC, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.ORCID 0000-0002-5916-3029

Funding

Deutsche Krebshilfe 74MSNZNGArGerman Cancer AidHochschulstiftung Medizin DresdenMedical Faculty Carl Gustav CarusMildred Scheel Early Career Center Dresden P2Mildred Scheel Early Career Center Dresden P2/German Cancer AidTechnische Universität Dresden
6 · The paper itself

Abstract

objectiveThis study evaluated the legibility, comprehension, and clinical usability of visual timelines for communicating cancer treatment paths. We examined how these visual aids enhance participants' and patients' understanding of their treatment plans. MATERIALS AND

methodsThe study included 2 online surveys and 1 in-person survey with hematology cancer patients. The online surveys involved 306 and 160 participants, respectively, while the clinical evaluation included 30 patients (11 re-surveyed) and 24 medical doctors. Participants were assessed on their ability to understand treatment paths provided with audio information alone or with visual aids. The study also evaluated the comprehensibility of key treatment terms and the ability of patients to recall their cancer treatment paths.

resultsVisual representations effectively communicated treatment terms, with 7 out of 8 terms achieving over 85% transparency as pictograms, compared to 5 out of 8 for comics and 4 out of 8 for photos. Visual treatment timelines improved the proportion of correct responses, increased confidence, and were rated higher in information quality than audio-only information. In the clinical evaluation, patients showed good comprehension (mean proportion correct: 0.82) and recall (mean proportion correct: 0.71 after several weeks), and both patients and physicians found the visual aids helpful. DISCUSSION: We discuss that visual timelines enhance patient comprehension and confidence in cancer communication. We also discuss limitations of the online surveys and clinical evaluation. The importance of accessible visual aids in patient consultations is emphasized, with potential benefits for diverse patient populations.

conclusionVisual aids in the form of treatment timelines improve the legibility and comprehension of cancer treatment paths. Both patients and physicians support integrating these tools into cancer treatment communication.

Indexed as

Audiovisual AidsCommunicationNeoplasmsPatient Education as TopicAdultAgedComprehensionFemaleHumansMaleMiddle AgedPhysician-Patient Relationsdata visualizationhealth communicationoncologytreatment communicationvisual aids

Identifiers

PMID39820364
PMCPMC11833489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.